Salt film encapsulated perfluorocarbons
July 23, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3879510 Microparticulate material and method of making such material Technique and system for coding and identifying materials Blood substitute and blood plasma expander comprising polyhemoglobin Injectable compositions, nanoparticles useful therein, and process of manufacturing same Lipid encapsulated hemoglobin cells Process for preparing artificial red cells Functional oxygen transport system Method of treatment of atherosclerosis and a balloon catheter for same Fluorocarbon tracers and tracing method InventorAssigneeApplicationNo. 734461 filed on 07/23/1991US Classes:424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)264/4.1, Liquid encapsulation utilizing an emulsion or dispersion to form a solid-walled microcapsule (includes liposome)424/490, Coated (e.g., microcapsules)424/497Containing solid synthetic polymersExaminersPrimary: Michl, Paul R.Assistant: Bawa, Raj Attorney, Agent or FirmForeign Patent References
International ClassA61K 009/50AbstractAn artificial blood substitute comprising Lewis acid--Lewis base salt film microcapsule having a perfluorocarbon encapsulated therein. The Lewis base may be a polyoxyalkylene adduct of an amine and the Lewis acid may be a polyoxyalkylene derivative of a polymeric acid.Other References
| |
